Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis

Int J Antimicrob Agents. 2009 Jan;33(1):92-3. doi: 10.1016/j.ijantimicag.2008.06.014. Epub 2008 Sep 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acetamides / administration & dosage*
  • Acetamides / adverse effects
  • Acetamides / pharmacology
  • Acetamides / therapeutic use
  • Adult
  • Anti-Infective Agents / administration & dosage*
  • Anti-Infective Agents / adverse effects
  • Anti-Infective Agents / pharmacology
  • Anti-Infective Agents / therapeutic use
  • Culture Media
  • Drug Administration Schedule
  • Drug Resistance, Multiple, Bacterial
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Extensively Drug-Resistant Tuberculosis / microbiology
  • Female
  • Humans
  • Korea
  • Linezolid
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / isolation & purification
  • Oxazolidinones / administration & dosage*
  • Oxazolidinones / adverse effects
  • Oxazolidinones / pharmacology
  • Oxazolidinones / therapeutic use
  • Sputum / microbiology
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / microbiology
  • Young Adult

Substances

  • Acetamides
  • Anti-Infective Agents
  • Culture Media
  • Oxazolidinones
  • Linezolid